Relay Therapeutics (RLAY) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free RLAY Stock Alerts $6.42 +0.11 (+1.74%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Relay Therapeutics Short Interest DataCurrent Short Volume11,530,000 sharesPrevious Short Volume10,690,000 sharesChange Vs. Previous Month+7.86%Dollar Volume Sold Short$75.18 millionShort Interest Ratio / Days to Cover9.4Last Record DateApril 30, 2024Outstanding Shares132,740,000 sharesPercentage of Shares Shorted8.69%Today's Trading Volume1,407,883 sharesAverage Trading Volume1,245,406 sharesToday's Volume Vs. Average113% Short Selling Relay Therapeutics ? Sign up to receive the latest short interest report for Relay Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRLAY Short Interest Over TimeRLAY Days to Cover Over TimeRLAY Percentage of Float Shorted Over Time Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Relay Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202411,530,000 shares $75.18 million +7.9%N/A9.4 $6.52 4/15/202410,690,000 shares $73.01 million -4.3%N/A9 $6.83 3/31/202411,170,000 shares $92.71 million -5.4%N/A10 $8.30 3/15/202411,810,000 shares $93.89 million +7.4%N/A10.9 $7.95 2/29/202411,000,000 shares $110.22 million +12.1%N/A10.5 $10.02 2/15/20249,810,000 shares $104.67 million +3.8%N/A9.2 $10.67 Get the Latest News and Ratings for RLAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20249,450,000 shares $87.41 million -16.3%11.0%9.5 $9.25 1/15/202411,290,000 shares $124.19 million -6.0%13.1%10.3 $11.00 12/31/202312,010,000 shares $132.23 million -12.3%14.1%10.4 $11.01 12/15/202313,700,000 shares $138.92 million -6.4%16.1%11.5 $10.14 11/30/202314,630,000 shares $115.72 million -0.1%17.3%12.1 $7.91 11/15/202314,640,000 shares $125.17 million +1.5%17.3%12.7 $8.55 10/31/202314,430,000 shares $95.24 million +4.8%16.9%12.9 $6.60 10/15/202313,770,000 shares $106.58 million -29.0%16.3%13.5 $7.74 9/30/202319,400,000 shares $163.15 million -3.4%22.9%19.9 $8.41 9/15/202320,080,000 shares $188.15 million +1.0%23.7%21 $9.37 8/31/202319,890,000 shares $203.28 million -3.9%23.5%19.1 $10.22 8/15/202320,700,000 shares $219.83 million +5.5%24.5%18.3 $10.62 7/31/202319,630,000 shares $247.34 million -1.1%23.3%16.4 $12.60 7/15/202319,840,000 shares $242.64 million -3.1%23.8%14.7 $12.23 6/30/202320,480,000 shares $257.23 million -2.9%24.6%12.1 $12.56 6/15/202321,080,000 shares $269.61 million -0.4%25.3%12.3 $12.79 5/31/202321,160,000 shares $235.72 million -1.5%25.4%13.1 $11.14 5/15/202321,480,000 shares $221.03 million +8.5%25.8%13.6 $10.29 4/30/202319,800,000 shares $225.13 million +1.4%23.4%13 $11.37 4/15/202319,530,000 shares $340.60 million +3.3%23.1%13.3 $17.44 3/31/202318,910,000 shares $311.45 million +5.5%22.4%15.4 $16.47 3/15/202317,930,000 shares $295.85 million +0.8%21.3%13.8 $16.50 2/28/202317,780,000 shares $287.15 million +3.0%21.1%13 $16.15 2/15/202317,270,000 shares $317.25 million -0.6%20.6%12.9 $18.37 1/31/202317,380,000 shares $372.97 million -6.9%20.7%13 $21.46 1/15/202318,660,000 shares $387.57 million +10.5%22.2%14.7 $20.77 12/30/202216,890,000 shares $252.34 million +25.8%20.0%13.8 $14.94 12/15/202213,430,000 shares $230.59 million +7.5%15.9%12.2 $17.17 11/30/202212,490,000 shares $232.06 million -4.3%14.8%11.1 $18.58 11/15/202213,050,000 shares $258.39 million -3.1%15.4%10.5 $19.80 10/31/202213,460,000 shares $299.08 million +3.1%16.5%10.9 $22.22 10/15/202213,060,000 shares $254.80 million +7.2%16.1%10.4 $19.51 9/30/202212,180,000 shares $272.47 million +4.0%15.0%10.2 $22.37 9/15/202211,710,000 shares $293.69 million -25.0%15.9%9.2 $25.08Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now RLAY Short Interest - Frequently Asked Questions What is Relay Therapeutics' current short interest? Short interest is the volume of Relay Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 11,530,000 shares of RLAY short. Learn More on Relay Therapeutics' current short interest. What is a good short interest ratio for Relay Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLAY shares currently have a short interest ratio of 9.0. Learn More on Relay Therapeutics's short interest ratio. Is Relay Therapeutics' short interest increasing or decreasing? Relay Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 11,530,000 shares, an increase of 7.9% from the previous total of 10,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relay Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Relay Therapeutics: Immatics (10.50%), Mesoblast Limited (0.79%), REGENXBIO Inc. (8.65%), CARGO Therapeutics, Inc. (13.99%), Autolus Therapeutics plc (1.32%), BioCryst Pharmaceuticals, Inc. (16.30%), HilleVax, Inc. (3.29%), Novavax, Inc. (32.00%), Scholar Rock Holding Co. (16.78%), Exscientia plc (3.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Relay Therapeutics stock? Short selling RLAY is an investing strategy that aims to generate trading profit from Relay Therapeutics as its price is falling. RLAY shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relay Therapeutics? A short squeeze for Relay Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLAY, which in turn drives the price of the stock up even further. How often is Relay Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLAY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: IMTX Short Squeeze MESO Short Squeeze RGNX Short Squeeze CRGX Short Squeeze AUTL Short Squeeze BCRX Short Squeeze HLVX Short Squeeze NVAX Short Squeeze SRRK Short Squeeze EXAI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLAY) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company